Skip to main content
Clinical Trials/CTRI/2016/10/007331
CTRI/2016/10/007331
Completed
未知

Comparision of efficacy of Haloperidol and Olanzapine in the treatment of Delirium

Government Medical College Hospital0 sites100 target enrollmentStarted: TBDLast updated:

Overview

Phase
未知
Status
Completed
Enrollment
100

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1\. Age of patients 18\-75 years. 2\) Patient should be verbally responsive. 3\) Patients or caregiver must give written consent for the study

Exclusion Criteria

  • 1\) Mechanically ventilated or mute patients. 2\) Patients of alcohol withdrawal delirium. 3\) Patients having history of dementia. 4\) Patients who had already been injected with antipsychotics in the emergency room or intensive care unit. 5\) Patients having hypersensitivity reaction to haloperidol or olanzapine in past.

Investigators

Similar Trials